Menu
GWAS Study

Genetic association analyses highlight biological pathways underlying mitral valve prolapse.

Dina C, Bouatia-Naji N, Tucker N et al.

26301497 PubMed ID
GWAS Study Type
12082 Participants
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

DC
Dina C
BN
Bouatia-Naji N
TN
Tucker N
DF
Delling FN
TK
Toomer K
DR
Durst R
PM
Perrocheau M
FL
Fernandez-Friera L
SJ
Solis J
LT
Le Tourneau T
CM
Chen MH
PV
Probst V
BY
Bosse Y
PP
Pibarot P
ZD
Zelenika D
LM
Lathrop M
HS
Hercberg S
RR
Roussel R
BE
Benjamin EJ
BF
Bonnet F
LS
Lo SH
DE
Dolmatova E
SF
Simonet F
LS
Lecointe S
KF
Kyndt F
RR
Redon R
LM
Le Marec H
FP
Froguel P
EP
Ellinor PT
VR
Vasan RS
BP
Bruneval P
MR
Markwald RR
NR
Norris RA
MD
Milan DJ
SS
Slaugenhaupt SA
LR
Levine RA
SJ
Schott JJ
HA
Hagege AA
JX
Jeunemaitre X
Chapter II

Abstract

Summary of the research findings

Nonsyndromic mitral valve prolapse (MVP) is a common degenerative cardiac valvulopathy of unknown etiology that predisposes to mitral regurgitation, heart failure and sudden death. Previous family and pathophysiological studies suggest a complex pattern of inheritance. We performed a meta-analysis of 2 genome-wide association studies in 1,412 MVP cases and 2,439 controls. We identified 6 loci, which we replicated in 1,422 cases and 6,779 controls, and provide functional evidence for candidate genes. We highlight LMCD1 (LIM and cysteine-rich domains 1), which encodes a transcription factor and for which morpholino knockdown of the ortholog in zebrafish resulted in atrioventricular valve regurgitation. A similar zebrafish phenotype was obtained with knockdown of the ortholog of TNS1, which encodes tensin 1, a focal adhesion protein involved in cytoskeleton organization. We also showed expression of tensin 1 during valve morphogenesis and describe enlarged posterior mitral leaflets in Tns1(-/-) mice. This study identifies the first risk loci for MVP and suggests new mechanisms involved in mitral valve regurgitation, the most common indication for mitral valve repair.

1,442 European ancestry cases, 2,439 European ancestry controls

Chapter III

Study Statistics

Key metrics and study information

12082
Total Participants
GWAS
Study Type
Yes
Replicated
1,422 European ancestry cases, 6,779 European ancestry controls
Replication Participants
European
Ancestry
U.S., Canada, U.K., Spain, France
Recruitment Country
Chapter IV

Analysis

Comprehensive review of health and genetic findings

Important Disclaimer: This review has been performed semi-automatically and is provided for informational purposes only. While we strive for accuracy, this analysis may contain errors, omissions, or misinterpretations of the original research. DNA Genics disclaims all liability for any inaccuracies, errors, or consequences arising from the use of this information. Users should independently verify all information and consult original research publications before making any decisions based on this content. This analysis is not intended as a substitute for professional scientific review or medical advice.

Analysis In Progress

Our analysis of this publication is currently being prepared. Please check back soon for comprehensive insights into the health and genetic findings discussed in this research.